Drugs / SGN-00101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00038714 | Nov 2001 → Jan 2004 | papilloma, recurrent respiratory papillomatosis | Nventa Biopharmaceuticals Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SGN-00101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00038714 ↗ |